Plasma and saliva concentrations for a new formulation of erythromycin stearate
- 1 January 1979
- journal article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 6 (2) , 118-123
- https://doi.org/10.1185/03007997909109408
Abstract
Erythromycin saliva and plasma concentrations were determined in 10 subjects after the first and fourth doses of a new formulation of erythromycin stearate ('Erythrocin'), 500 mg 8-hourly, taken immediately before food. Consistent absorption occurred and the steady state plasma levels compared favourably with the minimal inhibitory concentrations of erythromycin for common respiratory pathogens. There was a significant positive correlation between steady state saliva and plasma levels.Keywords
This publication has 1 reference indexed in Scilit:
- Micromethod for Assaying Serum Levels of ErythromycinApplied Microbiology, 1969